Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma

被引:3
|
作者
Wang, Huimin [1 ,2 ,3 ,4 ,5 ]
Yang, Xiaoang [1 ]
Sun, Guiying [3 ,4 ,5 ]
Yang, Qian [3 ,4 ,5 ]
Cui, Chi [1 ,3 ,4 ]
Wang, Xiao [1 ,3 ,4 ]
Ye, Hua [3 ,4 ,5 ]
Dai, Liping [1 ,3 ,4 ]
Shi, Jianxiang [1 ,3 ,4 ]
Zhang, Jianying [1 ,3 ,4 ]
Wang, Peng [1 ,3 ,4 ,5 ]
机构
[1] Zhengzhou Univ, Acad Med Sci, Henan Inst Med & Pharmaceut Sci, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Henan Key Lab Tumor Epidemiol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Peoples R China
[5] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
GNA11; tumor-associated antigen; autoantibody; immunodiagnosis; esophageal squamous cell carcinoma; DIAGNOSTIC BIOMARKER; CANCER; EXPRESSION; REPORTERS;
D O I
10.3389/fonc.2021.661043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study aims to explore the diagnostic value of anti-GNA11 autoantibody in esophageal squamous cell carcinoma (ESCC) from multiple levels. Autoantibody against GNA11 with the highest diagnostic performance was screened out from the customized protein microarray. A total of 486 subjects including ESCC patients and matched normal controls were recruited in the verification and validation phases by using enzyme-linked immunosorbent assay (ELISA). Western blotting analysis was used to verify the ELISA results. Immunohistochemistry (IHC) was used to evaluate GNA11 expression in ESCC tissues and para-tumor tissues. In addition, a bioinformatics approach was adopted to investigate the mRNA expression of GNA11 in ESCC. Results indicated that the level of anti-GNA11 autoantibody in ESCC patients was significantly higher than that in the normal controls, and it can be used to distinguish ESCC patients from normal individuals in clinical subgroups (p < 0.05), as revealed by both ELISA and Western blotting. The receiver operating characteristic (ROC) curve analysis showed that anti-GNA11 autoantibody could distinguish ESCC patients from normal controls with an area under the ROC curve (AUC) of 0.653, sensitivity of 10.96%, and specificity of 98.63% in the verification cohort and with an AUC of 0.751, sensitivity of 38.24%, and specificity of 88.82% in the validation cohort. IHC manifested that the expression of GNA11 can differentiate ESCC tissues with para-tumor tissues (p < 0.05), but it cannot be used to differentiate different pathological grades and clinical stages (p > 0.05). The mRNA expression of GNA11 in ESCC patients and normal controls was different with a bioinformatics mining with The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) data in Gene Expression Profiling Interactive Analysis (GEPIA). In summary, anti-GNA11 autoantibody has the potential to be a new serological marker in the diagnosis of ESCC.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma
    Tanaka, Hideaki
    Toyoshima, Takeshi
    Sonoda, Kenzo
    Kitamura, Ryoji
    Sasaguri, Masaaki
    Kawano, Shintaro
    Matsubara, Ryota
    Goto, Yuichi
    Nakamura, Seiji
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [33] The role of tumor-associated macrophages in oral squamous cell carcinoma
    Xue, Yiwen
    Song, Xiao
    Fan, Siyu
    Deng, Runzhi
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [34] Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines
    Sueoka, K
    Nawata, S
    Nakagawa, T
    Murakami, A
    Takeda, O
    Suminami, Y
    Kato, H
    Sugino, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (05) : 1345 - 1353
  • [35] Serological identification of tumor antigens of esophageal squamous cell carcinoma
    Shimada, H
    Nakashima, K
    Ochiai, T
    Nabeya, Y
    Takiguchi, M
    Nomura, F
    Hiwasa, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (01) : 77 - 86
  • [36] Using Proteomic Approach to Identify Tumor-Associated Proteins as Biomarkers in Human Esophageal Squamous Cell Carcinoma
    Zhang, Jintao
    Wang, Kaijuan
    Zhang, Jianzhong
    Liu, Samuel S.
    Dai, Liping
    Zhang, Jian-Ying
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (06) : 2863 - 2872
  • [37] Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma
    Y. Cheng
    J. Xu
    J. Guo
    Y. Jin
    X. Wang
    Q. Zhang
    L. Liu
    Clinical and Translational Oncology, 2013, 15 : 398 - 402
  • [38] Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma
    Cheng, Y.
    Xu, J.
    Guo, J.
    Jin, Y.
    Wang, X.
    Zhang, Q.
    Liu, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (05): : 398 - 402
  • [39] Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma
    Ye, Leiguang
    Guan, Songlei
    Zhang, Cong
    Lee, Kuang-Hui
    Sun, Shilong
    Wei, Jun
    Liu, Baogang
    TUMOR BIOLOGY, 2013, 34 (03) : 1873 - 1877
  • [40] Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
    Chen, Huili
    Sun, Guiying
    Han, Zhuo
    Wang, Huimin
    Li, Jiaxin
    Ye, Hua
    Song, Chunhua
    Zhang, Jianying
    Wang, Peng
    MEDICINA-LITHUANIA, 2022, 58 (10):